RADIOSURGICAL TREATMENT FOR BRAIN METASTASES OF OVARIAN CANCER
https://doi.org/10.22328/2079-5343-2020-11-3-104-110
Abstract
Introduction. Radiosurgical treatment is the method of choice for brain metastases. In clinical practice, there are tumors with a relatively small frequency of secondary brain damage, for which the use of stereotactic radiosurgery has not been studied enough. One example of such diseases is malignant tumors of the female reproductive system.
Materials and methods. We described the application of stereotactic radiosurgery of ovarian cancer metastases to the brain using a three-fold hypofractionated stereotactic radiosurgery. We resorted to this method in order to reduce the negative effect on the functional area of the brain and preserve the performance of radiation in the treatment of metastasis located in the subcortical nuclei. To evaluate the results, were performed magnetic resonance imaging and volumetry of pathological volume in the program for planning stereotactic radiosurgery Leksell Gamma plan® 10.1.
Results. Long term local control was observed on the part of all irradiated tumors with the same results of single irradiation and hypofractionated radiosurgery. Discussion. If there is a restriction to conduct a stereotactic radiosurgery associated with the localization of a pathological focus in the eloquent zone of the brain, it is possible to irradiate it in the hypofractionation mode. The method provides local control of tumor growth without a high risk of radiation toxicity.
About the Authors
A. S. Tokarev
N.V. Sklifosovsky Research Institute for Emergency Medicine of the Moscow Healthcare Department
Russian Federation
Moscow
Russian Federation
Moscow
O. L. Evdokimova
N.V. Sklifosovsky Research Institute for Emergency Medicine of the Moscow Healthcare Department
Russian Federation
Moscow
Russian Federation
Moscow
V. A. Rak
N.V. Sklifosovsky Research Institute for Emergency Medicine of the Moscow Healthcare Department
Russian Federation
Moscow
Russian Federation
Moscow
O. A. Viktorova
N.V. Sklifosovsky Research Institute for Emergency Medicine of the Moscow Healthcare Department
Russian Federation
Moscow
Russian Federation
Moscow
References
1. Urmancheeva AF, Meshkova IE. Questions of epidemiology and diagnostics of ovarian cancer. Practical Oncology, 2000, Vol. 1, No 4, рp. 7–13 (In Russ.).
2. Zhordania K.I., Payanidi Yu.G., Kalinicheva E.V. Two ways of development of serous ovarian cancer. Oncogynecology, 2014, No 3, рp. 42–48 (In Russ.).
3. Morgan R.J., Armstrong D.K., Alvarez R.D., Bakkum-Gamez J.N., Behbakht K., Chen L.M. et al. Ovarian Cancer, Version 1.2016, NCCN clinical practice guidelines in oncology // J. Natl. Compr. Canc. Netw. 2016. Vol. 14, No. 9. P. 1134–1163. doi: 10.6004/jnccn.2016.0122.
4. Cohen Z.R., Suki D., Weinberg J.S. Marmor E., Lang F.F., Gershenson D.M., Sawaya R. Brain metastases in patients with ovarian carcinoma: prognostic factors and out-come // J. Neurooncol. 2004. Vol. 66 (3). Р. 313–325. PMID: 15015663.
5. Cormio G., Maneo A., Parma G., Pittelli M.R., Miceli M.D., Bonazzi C. Central nervous system metastases in patients with ovarian carcinoma. A report of 23 cases and a literature review // Ann. Oncol. 1995. Vol. 6, No 6. P. 571–574. doi: 10.1093/oxfordjournals.annonc.a059246.
6. Koul A., Loman N., Malander S., Borg A., Ridderheim M. Two BRCA1-positive epithelial ovarian tumors with metastases to the central nervous system: a case report // Gynecol. Oncol. 2001. Vol. 80, No. 3. P. 399–402. doi: 10.1006/gyno.2000.6085.
7. Anupol N., Ghamande S., Odunsi K., Driscoll D., Lele S. Evaluation of prognostic factors and treatment modalities in ovarian cancer patients with brain metastases // Gynecol. Oncol. 2002; Vol.85, 3. P.487–492. doi: 10.1006/gyno.2002.6653.
8. Chen Y.L., Cheng W.F., Hsieh C.Y., Chen C.A. Brain metastasis as a late manifestation of ovarian carcinoma // Eur. J. Canc. Care (Engl). 2011; Vol. 20, 1. P.44–49. DOI:10.1111/j.1365–2354.2009.01133.x.
9. Niranjan A., Lunsford L.D., Kano H. eds. Leksell Radiosurgery. Guidelines for Multiple Brain Metastases Radiosurgery. Prog Neurol Surg. Basel, Karger. 2019; Vol. 34. P. 100–109. DOI: 10.1159/000493055.
10. Gadducci A., Tana R., Teti G., Fanucchi A., Pasqualetti F., Cionini L., Genazzani A.R. Brain recurrences in patients with ovarian cancer: report of 12 cases and review of the literature // Anticancer. Res. 2007; Vol. 27, 6C. P.4403–4409.
11. Geisler J.P., Geisler H.E. Brain metastases in epithelial ovarian carcinoma // Gynecol. Oncol. 1995. Vol. 57, No. 2. P. 246–249. doi: 10.1006/gyno.1995.1134.
12. Kolomainen D.F., Larkin J.M., Badran M., A’Hern R.P., King D.M., Fisher C., Bridges J.E., Blake P.R., Barton D.P., Shepherd J.H., Kaye S.B., Gore M.E. Epithelial ovarian cancer metastasizing to the brain: a late manifestation of the disease with an increasing incidence // J. Clin. Oncol. 2002; Vol. 20, No. 4. P. 982–986. doi: 10.1200/JCO.2002.20.4.982.
13. Andrews D.W., Scott C.B., Sperduto P.W. Flanders A.E., Gaspar L.E., Schell M.C., Werner-Wasik M., Demas W., Ryu J., Bahary J.P., Souhami L., Rotman M., Mehta M.P., Curran WJ. Jr. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: Phase EH results of the RTOG 9508 randomised trial // Lancet. 2004. Vol. 363, No. 9422. P. 1665–1672. doi: 10.1016/S0140-6736(04)16250-8.
14. Pietzner K., Oskay-Oezcelik G., El Khalfaoui K., Boehmer D., Lichtenegger W., Sehouli J. Brain Metastases from Epithelial Ovarian Cancer: Overview and Optimal Management // Anticancer Res. 2009. Vol. 29, No. 7. P. 2793–2798.
15. Vlasveld L.T., Beynen J.H., Boogerd W., Ten Bokkel Huinink W.W., Rodenhuis S. Complete remission of brain metastases of ovarian cancer following high-dose carboplatin: a case report and pharmacokinetic study // Cancer Chemother. Pharmacol. 1990. Vol. 25, No. 5. P. 382–383. doi: 10.1007/bf00686244.
16. Plaxe S.C., Dottino P.R., Goodman H.M., Deligdisch L., Idelson M., Cohen C.J. Clinical features of advanced ovarian mixed mesodermal tumors and treatment with doxorubicin- and cis-platinum-based chemotherapy // Gynecol. Oncol. 1990. Vol. 37, No. 2. P. 244–249. doi: 10.1016/0090.8258(90)90341-h.
17. Pectasides D., Pectasides M., Economopoulos T. Brain metastases from epithelial ovarian cancer: a review of the literature // Oncologist. 2006. Vol. 11, No. 3. P. 252–260. doi: 10.1634/theoncologist.11.3-252
18. Rodriguez G.C., Soper J.T., Berchuck A., Oleson J., Dodge R., Montana G., Clarke-Pearson D.L. Improved palliation of cerebral metastases in epithelial ovarian cancer using a combined modality approach including radiation therapy, chemotherapy, and surgery // J. Clin. Oncol. 1992. Vol. 10, No. 10. P. 1553–1560. doi: 10.1200/JCO.1992.10.10.1553
19. Cohen Z.R., Suki D., Weinberg J.S., Marmor E., Lang F.F., Gershenson D.M., Sawaya R. Brain metastases in patients with ovarian carcinoma: prognostic factors and outcome // J. Neurooncol. 2004. Vol. 66, No. 3. P. 313–325. doi: 10.1023/b:neon.0000014516.04943.38
20. Pakneshan S., Safarpour D., Tavassoli F., Jabbari B. Brain metastasis from ovarian cancer: a systematic review // J. Neurooncol. 2014. Vol. 119, No. 1. P. 1–6. doi: 10.1007/s11060-014-1447-9.
21. Boyd T.S, Mehta M.P. Stereotactic radiosurgery for brain metastases // Oncology (Williston Park). 1999. Vol. 13, No. 10. P. 1397–1409.
22. Aoyama H., Shirato H., Onimaru R., Kagei K., Ikeda J., Ishii N., Sawamura Y., Miyasaka K. Hypofractionated stereotactic radiotherapy alone without wholebrain irradiation for patients with solitary and oligo brain metastasis using noninvasive fixation of the skull // Int. J. Radiat. Oncol. Biol. Phys. 2003. Vol. 56, No. 3. P. 793–800. doi: 10.1016/s0360-3016(03)00014-2.
23. Higuchi Y., Serizawa T., Nagano O., Matsuda S., Ono J., Sato M., Iwadate Y., Saeki N. Three-staged stereotactic radiotherapy without whole brain irradiation for large metastatic brain tumors // Int. J. Radiat. Oncol. Biol. Phys. 2009. Vol. 74, No. 5. P. 1543–1548. doi: 10.1016/j.ijrobp.2008.10.035.
24. Song C.W., Cho L.C., Yuan J., Dusenbery K.E., Griffin R.J., Levitt S.H. Radiobiology of stereotactic body radiation therapy/stereotactic radiosurgery and the linear-quadratic model // Int. J. Radiat. Oncol. Biol. Phys. 2013. Vol. 87, No. 1. P. 18–19. doi: 10.1016/j.ijrobp.2013.03.013.
Review
For citations:
Tokarev A.S., Evdokimova O.L., Rak V.A., Viktorova O.A. RADIOSURGICAL TREATMENT FOR BRAIN METASTASES OF OVARIAN CANCER. Diagnostic radiology and radiotherapy. 2020;11(3):104-110. (In Russ.) https://doi.org/10.22328/2079-5343-2020-11-3-104-110
Views:
597
Email this article 